Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion type Assertion NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_head.
- NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion wasGeneratedBy ECO_0000203 NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_provenance.
- NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion wasDerivedFrom befree-20150227 NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_provenance.
- NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion SIO_000772 15314693 NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_provenance.
- NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion evidence source_evidence_literature NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_provenance.
- NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_assertion description "[Our results suggest that (a) deficiency in MIC-NKG2D immune surveillance may contribute to prostate cancer progression, (b) sMIC may be a novel biomarker for prostate cancer, and (c) using cytokines to restore MIC-NKG2D-mediated immunity may have clinical significance for prostate cancer in cell-based adaptive immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865693.RAdVGnprwV1kt_jKix6k7zXoQ4WWdf3-FaEdxcYXWy_tI130_provenance.